Drawing for IMPERATIVE

USPTO serial 97822109

IMPERATIVE

Reviewed by CopyMark Law Group

Status 733Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
HUGHES, ROSE
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 733: Status 733 means the fourth six-month extension was granted. Only one extension typically remains before you must file a Statement of Use or risk abandonment.

Need help with IMPERATIVE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $449*

Plus Government fees of $450

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Steven J. Nataupsky

Steven J. Nataupsky KNOBBE, MARTENS, OLSON & BEAR, LLP2040 MAIN STREET, 14TH FLOORIRVINE, CA 92614United States

Goods and services

ClassDescriptionStatusFirst use
010Medical devices, namely, catheters, stents, guidewires, drug delivery systems, wearable monitors for monitoring vital signs, stroke rehabilitation devices in the nature of physical, cognitive, and speech-language-pathology rehabilitation devices; Digital health devices in the nature of digital monitoring devices, for use in telemedicine, and for use in behavioral health and community health, for monitoring biomarkers of patients; Medical devices for the detection, diagnosis, and treatment of strokes, and physical and neuro rehabilitation devices for use with stroke patients; Medical catheters and medical catheter sheaths for use in dialysis and treating deep vein thrombosis, coronary occlusions, and peripheral artery occlusions; Medical, surgical and healthcare apparatus and instruments, namely, thrombus removal devices, clot removal devices, emboli removal devices, catheters, catheters for treating deep vein thrombosis, catheters for treating peripheral arterial occlusions, dialysis catheters, aspiration control handles, vacuum pumps, tubing sets comprised of medical tubing for use with catheters, blood filters, and parts and fittings for the aforementioned goods; Medical, surgical and healthcare apparatus and instruments, namely, medical and surgical apparatus and instruments for use in thrombus clot, clot, and emboli removal; Catheters; Catheters for treating pulmonary embolisms and deep vein thrombosis; Catheters used in dialysis; Catheters for treating peripheral arterial occlusions; Catheters for treating coronary occlusions; Medical devices, namely, aspiration control handles; Vacuum pumps for medical purposes; Tubing sets comprised of medical tubing for removal of blood and thrombus, aspiration, and removing occlusions, filters and parts and fittings for the aforementioned goods; Robotic devices for use in connection with transvascular medical procedures; Robotic catheter drive systems comprised of a motorized catheter positioner having rotational and translational movement capability and a tele-robotic controller with rotation, translation and deflection control buttons, to facilitate remote catheterizations, for use in transvascular medical procedures; Robotic guidewire drive systems for use in transvascular medical procedures; Medical devices for automated movement in the nature of a robotic system comprising motors having rotational and/or translational movement capability for use in robotic control of catheters and/or guidewires; Surgical instruments and apparatus for use in transvascular medical procedures, namely, computerized surgical control systems comprising a medical endoscope, computer hardware, and installed firmware for controlling and operating surgical robots and surgical instrumentsACTIVE—
012Surgical carts for use in transvascular medical proceduresACTIVE—
044Medical services; Medical services in connection with the detection, diagnosis, treatment and physical and neuro rehabilitation of stroke patients; Holistic health services; Providing health care services in the field of vascular disease and strokesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 9, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 9, 2026EX4GSOU EXTENSION 4 GRANTED—
Sep 8, 2026EXT4SOU EXTENSION 4 FILED—
Sep 8, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 10, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 10, 2026EX3GSOU EXTENSION 3 GRANTED—
Mar 9, 2026EXT3SOU EXTENSION 3 FILED—
Mar 9, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 15, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 8, 2025EX2GSOU EXTENSION 2 GRANTED—
Sep 8, 2025EXT2SOU EXTENSION 2 FILED—
Sep 8, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 11, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 10, 2025EX1GSOU EXTENSION 1 GRANTED—
Mar 10, 2025EXT1SOU EXTENSION 1 FILED—
Mar 10, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 10, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 16, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 16, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 16, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 16, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 26, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 7, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 5, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 4, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 4, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 4, 2024XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Mar 4, 2024XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Dec 4, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 4, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 4, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 1, 2023DOCKASSIGNED TO EXAMINER—
Mar 23, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 7, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance